Response of the Urothelial Carcinoma Cell Lines to Cisplatin

Cisplatin (CDDP)-based chemotherapy is the standard of care in patients with muscle-invasive bladder cancer. However, in a large number of cases, the disease becomes resistant or does not respond to CDDP, and thus progresses and disseminates. In such cases, prognosis of patients is very poor. CDDP m...

Descripción completa

Detalles Bibliográficos
Autores principales: Holíčková, Andrea, Roška, Jan, Órásová, Eveline, Bruderová, Vladimíra, Palacka, Patrik, Jurkovičová, Dana, Chovanec, Miroslav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604399/
https://www.ncbi.nlm.nih.gov/pubmed/36293346
http://dx.doi.org/10.3390/ijms232012488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604399/
https://www.ncbi.nlm.nih.gov/pubmed/36293346
http://dx.doi.org/10.3390/ijms232012488

Ejemplares similares